Pentoxifylline and electromagnetic field improved bone fracture healing in rats
dc.contributor.author | Atalay, Yusuf | |
dc.contributor.author | Gunes, Nedim | |
dc.contributor.author | Guner, Mehmet Dervis | |
dc.contributor.author | Akpolat, Veysi | |
dc.contributor.author | Celik, Mustafa Salih | |
dc.contributor.author | Guner, Rezzan | |
dc.date.accessioned | 2024-04-24T17:18:27Z | |
dc.date.available | 2024-04-24T17:18:27Z | |
dc.date.issued | 2015 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | Background: The aim of this study was to evaluate the effects of a phosphodiesterase inhibitor pentoxifylline (PTX), electromagnetic fields (EMFs), and a mixture of both materials on bone fracture healing in a rat model. Materials and methods: Eighty male Wistar rats were randomly divided into four groups: Group A, femur fracture model with no treatment; Group B, femur fracture model treated with PTX 50 mg/kg/day intraperitoneal injection; Group C, femur fracture model treated with EMF 1.5 +/- 0.2 Mt/50 Hz/6 hours/day; and Group D, femur fracture model treated with PTX 50 mg/kg/day intraperitoneal injection and EMF 1.5 +/- 0.2 Mt/50 Hz/6 hours/day. Results: Bone fracture healing was significantly better in Group B and Group C compared to Group A (P<0.05), but Group D did not show better bone fracture healing than Group A (P>0.05). Conclusion: It can be concluded that both a specific EMF and PTX had a positive effect on bone fracture healing but when used in combination, may not be beneficial. | en_US |
dc.description.sponsorship | Dicle University | en_US |
dc.description.sponsorship | This study was supported by the Scientific Research Projects of Dicle University. | en_US |
dc.identifier.doi | 10.2147/DDDT.S89669 | |
dc.identifier.endpage | 5201 | en_US |
dc.identifier.issn | 1177-8881 | |
dc.identifier.pmid | 26388687 | |
dc.identifier.scopus | 2-s2.0-84941254117 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 5195 | en_US |
dc.identifier.uri | https://doi.org/10.2147/DDDT.S89669 | |
dc.identifier.uri | https://hdl.handle.net/11468/18788 | |
dc.identifier.volume | 9 | en_US |
dc.identifier.wos | WOS:000361015500002 | |
dc.identifier.wosquality | Q2 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Dove Medical Press Ltd | en_US |
dc.relation.ispartof | Drug Design Development and Therapy | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Bones | en_US |
dc.subject | Electromagnetic Fields | en_US |
dc.subject | Fracture Healing | en_US |
dc.subject | Phosphodiesterase Inhibitor | en_US |
dc.subject | Pentoxifylline | en_US |
dc.subject | Rats | en_US |
dc.title | Pentoxifylline and electromagnetic field improved bone fracture healing in rats | en_US |
dc.title | Pentoxifylline and electromagnetic field improved bone fracture healing in rats | |
dc.type | Article | en_US |